Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders, particularly Generalized Anxiety Disorder (GAD), and for short-term relief of anxiety symptoms. The drug has shown efficacy even in patients with coexisting depressive symptoms. Long-term effectiveness beyond 3-4 weeks remains unestablished, requiring periodic reassessment by physicians.
Usage: Buspirone hydrochloride is indicated for managing anxiety disorders and providing short-term relief from anxiety symptoms. It is particularly effective for patients with Generalized Anxiety Disorder (GAD), including those with coexisting depressive symptoms. Long-term efficacy has not been established, and periodic reassessment is recommended.
Usage: Buspirone hydrochloride capsules are indicated for managing anxiety disorders and providing short-term relief from anxiety symptoms. It is effective in patients with Generalized Anxiety Disorder (GAD), including those with mild coexisting depressive symptoms, but long-term efficacy beyond 3 to 4 weeks has not been established.
Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders and providing short-term relief of anxiety symptoms, particularly for patients with Generalized Anxiety Disorder (GAD) who may also experience depressive symptoms. Long-term efficacy beyond a few weeks remains unproven, necessitating periodic reassessment by healthcare providers.
Usage: CYMBALTA® is indicated for the treatment of major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in adults and those 13+), and chronic musculoskeletal pain in adults.